Dysregulated mTORC1 renders cells critically dependent on desaturated lipids for survival under tumor-like stress

Regina M Young1, Daniel Ackerman, Zachary L Quinn

  • 1Abramson Family Cancer Research Institute.

Genes & Development
|May 24, 2013
PubMed

Insights

Constitutive mTORC1 activity makes hypoxic cancer cells reliant on external unsaturated lipids. Lack of these lipids triggers unfolded protein response and cell death, a process reversible with unsaturated lipid supplementation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Solid tumors feature heterogeneous microenvironments with limited nutrients like oxygen and glucose.
  • The impact of oncogenic mutations on cellular stress responses and survival in these environments is not fully understood.

Purpose of the Study:

  • To investigate how constitutive mammalian target of rapamycin complex 1 (mTORC1) activity affects cellular responses to hypoxia.
  • To determine the role of lipids in cell survival under nutrient-limiting conditions in cancer cells with dysregulated growth pathways.

Main Methods:

  • Utilized Tsc2(-/-) (tuberous sclerosis complex 2(-/-)) cells to model constitutive mTORC1 activity under hypoxic conditions.
  • Assessed the unfolded protein response (UPR), endoplasmic reticulum (ER) expansion, and cell death pathways.
  • Investigated the effect of exogenous unsaturated lipid supplementation on cell survival.

Main Results:

  • Hypoxic Tsc2(-/-) cells with limited serum lipids showed a magnified UPR and inositol-requiring protein-1 (IRE1)-dependent cell death due to failed ER expansion.
  • Cell death was reversed by adding unsaturated lipids, indicating a dependency.
  • UPR activation and apoptosis were observed in Tsc2-deficient kidney tumors and multiple human cancer cell lines.

Conclusions:

  • Constitutive mTORC1 activity induces a dependency on exogenous desaturated lipids in hypoxic cancer cells.
  • Cancer cells in ischemic tumor microenvironments struggle to balance lipid and protein synthesis due to desaturated lipid deficiency, leading to cell death.
  • Targeting lipid metabolism could be a therapeutic strategy for cancers with dysregulated mTORC1 signaling.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...